BDBM400820 QL-XII-45::US10000483, Compound II-13

SMILES Nc1ccc(cn1)-c1ccc2ncc3ccc(=O)n(-c4ccc5CCN(C(=O)C=C)c5c4)c3c2c1

InChI Key InChIKey=GXANJKDFGYJBEM-UHFFFAOYSA-N

Data  11 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 11 hits for monomerid = 400820   

TargetCytoplasmic tyrosine-protein kinase BMX(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM400820(QL-XII-45 | US10000483, Compound II-13)
Affinity DataIC50: 13.3nMAssay Description:Purified BMX was mixed with substrate (FAK or Bmxtides), kinase buffer (final 20 mM HEPES, pH 7.5, 10 mM MgCl2, 20 mM β-glycerophosphate, 1 mM d...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM400820(QL-XII-45 | US10000483, Compound II-13)
Affinity DataIC50: 6nMAssay Description:DiscoverX binding assays were performed according to published methods (Fabian et al., Nat. Biotechnol. 23, 329-36 (2005); Davis et al., Nat. Biotech...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetCytoplasmic tyrosine-protein kinase BMX(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM400820(QL-XII-45 | US10000483, Compound II-13)
Affinity DataIC50: 13nMAssay Description:DiscoverX binding assays were performed according to published methods (Fabian et al., Nat. Biotechnol. 23, 329-36 (2005); Davis et al., Nat. Biotech...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase mTOR(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM400820(QL-XII-45 | US10000483, Compound II-13)
Affinity DataIC50: 98nMAssay Description:DiscoverX binding assays were performed according to published methods (Fabian et al., Nat. Biotechnol. 23, 329-36 (2005); Davis et al., Nat. Biotech...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase Blk(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM400820(QL-XII-45 | US10000483, Compound II-13)
Affinity DataIC50: 300nMAssay Description:DiscoverX binding assays were performed according to published methods (Fabian et al., Nat. Biotechnol. 23, 329-36 (2005); Davis et al., Nat. Biotech...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase Tec(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM400820(QL-XII-45 | US10000483, Compound II-13)
Affinity DataIC50: 27nMAssay Description:DiscoverX binding assays were performed according to published methods (Fabian et al., Nat. Biotechnol. 23, 329-36 (2005); Davis et al., Nat. Biotech...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK3(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM400820(QL-XII-45 | US10000483, Compound II-13)
Affinity DataIC50: 5.64E+3nMAssay Description:DiscoverX binding assays were performed according to published methods (Fabian et al., Nat. Biotechnol. 23, 329-36 (2005); Davis et al., Nat. Biotech...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2020
Entry Details
Go to US Patent

TargetCytoplasmic tyrosine-protein kinase BMX(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM400820(QL-XII-45 | US10000483, Compound II-13)
Affinity DataIC50: 13nMAssay Description:Inhibition of recombinant full length His-tagged human BMX expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2020
Entry Details Article
PubMed
TargetTyrosine-protein kinase BTK(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM400820(QL-XII-45 | US10000483, Compound II-13)
Affinity DataIC50: 6nMAssay Description:Inhibition of BTK autophosphorylation at Y223 in anti-IgM stimulated human MOLM13 cells after 4 hrs by chemiluminescence assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2020
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM400820(QL-XII-45 | US10000483, Compound II-13)
Affinity DataIC50: 5.64E+3nMAssay Description:Inhibition of recombinant GST-tagged human JAK3 expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincubated for 1 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2020
Entry Details Article
PubMed
TargetTyrosine-protein kinase Blk(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM400820(QL-XII-45 | US10000483, Compound II-13)
Affinity DataIC50: 300nMAssay Description:Inhibition of recombinant full length His-tagged human BLK expressed in baculovirus expression system using poly (4:1 Glu, Tyr) as substrate preincub...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/24/2020
Entry Details Article
PubMed